This topic contains a solution. Click here to go to the answer

Author Question: Which of the following therapeutic alliance questionnaires includes a scale to assess a client's ... (Read 128 times)

joblessjake

  • Hero Member
  • *****
  • Posts: 555
Which of the following therapeutic alliance questionnaires includes a scale to assess a client's ability to self-disclose and reflect on the therapy session?
 
  a) California Psychotherapy Alliance Scale
  b) Helping Alliance Questionnaire
  c) Working Alliance Questionnaire
  d) None of the above

Question 2

The dynamics of the transition stage are driven by
 
  a. anxiety and fear.
  b. confusion and anxiety.
  c. anger and fear.
  d. confusion and anger.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bblaney

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

a

Answer to Question 2

a




joblessjake

  • Member
  • Posts: 555
Reply 2 on: Jul 31, 2018
:D TYSM


vickybb89

  • Member
  • Posts: 347
Reply 3 on: Yesterday
Excellent

 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

Opium has influenced much of the world's most popular literature. The following authors were all opium users, of varying degrees: Lewis Carroll, Charles, Dickens, Arthur Conan Doyle, and Oscar Wilde.

Did you know?

Side effects from substance abuse include nausea, dehydration, reduced productivitiy, and dependence. Though these effects usually worsen over time, the constant need for the substance often overcomes rational thinking.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library